Omaha, NEBRASKA3 Active Studies

Chronic Lymphocytic Leukemia Clinical Trials in Omaha, NEBRASKA

Find 3 actively recruiting chronic lymphocytic leukemia clinical trials in Omaha, NEBRASKA. Connect with local research sites and explore new treatment options.

3
Active Trials
3
Sponsors
476
Enrolling

Recruiting Chronic Lymphocytic Leukemia Studies in Omaha

About Chronic Lymphocytic Leukemia Clinical Trials in Omaha

Chronic lymphocytic leukemia (CLL) is a slow-growing cancer of the blood and bone marrow that affects B lymphocytes. It is the most common type of adult leukemia. Treatment options include targeted therapies, chemotherapy, and immunotherapy.

There are currently 3 chronic lymphocytic leukemia clinical trials recruiting participants in Omaha, NEBRASKA. These studies are seeking a combined 476 participants. Research is being sponsored by Eli Lilly and Company, Genentech, Inc., BeiGene. Clinical trial participation is free and participants receive study-related medical care at no cost.

Chronic Lymphocytic Leukemia Clinical Trials in Omaha — FAQ

Are there chronic lymphocytic leukemia clinical trials in Omaha?

Yes, there are 3 chronic lymphocytic leukemia clinical trials currently recruiting in Omaha, NEBRASKA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Omaha?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Omaha research site will contact you about next steps.

Are clinical trials in Omaha free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Omaha studies also compensate for your time and travel.

What chronic lymphocytic leukemia treatments are being tested?

The 3 active trials in Omaha are testing new therapies including novel drugs, biologics, and treatment approaches for chronic lymphocytic leukemia.

Data updated March 2, 2026 from ClinicalTrials.gov